{"id":2795,"date":"2021-04-08T05:00:00","date_gmt":"2021-04-08T05:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/conference-call-on-interim-report-9\/"},"modified":"2021-04-08T05:00:00","modified_gmt":"2021-04-08T05:00:00","slug":"conference-call-on-interim-report-9","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-9\/","title":{"rendered":"Conference call on Interim Report"},"content":{"rendered":"
\n

Invitation to attend XVIVO Perfusion\u2019s conference call regarding the presentation of the interim report January – March 2021. The presentation will be held in English<\/strong><\/p>\n<\/div>\n

\n

Time: Wednesday, April 21, 2021 at 2.00 p.m. CET
Information regarding the conference can be found under the following link:
https:\/\/onlinexperiences.com\/Launch\/QReg\/ShowUUID=2004FDA6-AE15-4016-8E25-4BF9A3FC2796<\/a>
Phone numbers to the conference:
Sweden: +46 856642651 PIN: 16950415#
UK: +44 3333000804 PIN: 16950415#
USA: +1 6319131422 PIN: 16950415#
\u00a0
Conference name: XVIVO Perfusion Interim Report Q1, conference ID: EV00122810
\u00a0
Participants from XVIVO Perfusion:
Dag Andersson, CEO
Kristoffer Nordstr\u00f6m, CFO
\u00a0
The press release for XVIVO Perfusion\u2019s interim report January \u2013 March 2021 will be released on April 21, 2021 at 7:30 a.m. CET.
\u00a0
Before the conference call, slides will be available at the company web page, www.xvivoperfusion.com\/corporate\/.<\/a>
\u00a0
April, 2021
Gothenburg
XVIVO Perfusion AB (publ)<\/p>\n<\/div>\n

\n

For further information, please contact:<\/strong><\/p>\n\n

Dag Andersson, CEO, +46 76 643 30 31, e-mail:\u00a0dag.andersson@xvivoperfusion.com<\/a>
Kristoffer\u00a0Nordstr\u00f6m, CFO, +46 73 519 21 64, e-mail:\u00a0kristoffer.nordstrom@xvivoperfusion.com<\/p>\n<\/div>\n

\n

About Us<\/strong><\/p>\n\n

XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in Lund, Sweden,\u00a0one\u00a0office\u00a0in\u00a0Groningen,\u00a0the\u00a0Netherlands and one office in\u00a0Denver, USA. The XVIVO share is listed on Nasdaq Stockholm and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com.<\/a><\/p>\n<\/div>\n

\n

Attachments<\/strong><\/p>\n\n

Conference call on Interim Report<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Invitation to attend XVIVO Perfusion\u2019s conference call regarding the presentation of the interim report January – March 2021. The presentation…<\/p>\n","protected":false},"template":"","class_list":["post-2795","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-ci"],"acf":[],"yoast_head":"\nConference call on Interim Report - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-9\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conference call on Interim Report - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Invitation to attend XVIVO Perfusion\u2019s conference call regarding the presentation of the interim report January – March 2021. The presentation...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-9\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-9\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-9\\\/\",\"name\":\"Conference call on Interim Report - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2021-04-08T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-9\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-9\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-9\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conference call on Interim Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conference call on Interim Report - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-9\/","og_locale":"en_US","og_type":"article","og_title":"Conference call on Interim Report - XVIVO","og_description":"Invitation to attend XVIVO Perfusion\u2019s conference call regarding the presentation of the interim report January – March 2021. The presentation...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-9\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-9\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-9\/","name":"Conference call on Interim Report - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2021-04-08T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-9\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-9\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-9\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Conference call on Interim Report"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}